Beijing Homa Bioengineering Co., Ltd. carried out clinical research on COVID-19IgM/IgG Antibody test kits at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology from October 12, 2020 to October 16, 2020. The results of clinical experiments showed that the comparison results of Homa'sIgM/IgG antibody test kits and nucleic acid testing (PCR) showed a negativerate of 99% and a positive rate of 97.6%. In comparison between Homa and other 3rd-party antibody test kits who have obtained the NMPA registration certificate, the IgG positivecoincidence rate is 100%, the IgG negativecoincidence rate is 100%, the IgM positive coincidence rate is 95%, and the IgM negative coincidence rate is 99.4 %.

Attached a summary of clinical research results: